Treasury Chief Reeves Aims for Specific Action on Household Expenses in Upcoming Budget

Chancellor Rachel Reeves has revealed she is planning "targeted steps to address cost of living issues" in next month's financial statement.

During an interview with media outlets, she noted that curbing price rises is a joint task of both the government and the Bank of England.

The United Kingdom's inflation rate is expected to be the most elevated among the G7 advanced economies this year and the following year.

Potential Utility Cost Measures

Reports indicate the government could take action to reduce utility costs, for example by slashing the current 5% level of value-added tax charged on energy.

An additional approach is to lower some of the regulatory levies currently included in bills.

Budgetary Limitations and Expert Predictions

The government will obtain the latest assessment from the independent fiscal watchdog, the OBR, on Monday, which will clarify how much room there is for such measures.

The consensus from most economists is that the Chancellor will have to announce tax rises or expenditure reductions in order to fulfill her declared borrowing rules.

Previously on Thursday, estimates indicated there was a £22 billion shortfall for the chancellor to resolve, which is at the lower end of forecasts.

"It is a shared job between the central bank and the administration to continue tackling some of the causes of price increases," Reeves informed the BBC in Washington, at the annual meetings of the International Monetary Fund and World Bank.

Tax Commitments and Global Concerns

While much of the focus has been on likely tax rises, the Treasury chief said the latest data from the OBR had not changed her vow to election pledges not to increase tax levels on earnings tax, sales tax or social security contributions.

She blamed an "uncertain world" with growing geopolitical and commercial issues for the Budget tax moves, likely to be targeted on those "with the broadest shoulders."

Global Trade Disputes

Addressing concerns about the UK's commercial links with the Asian nation she said: "The UK's national security invariably take priority."

Recent statement by Chinese authorities to increase export controls on critical minerals and other resources that are essential for high-technology manufacturing led US President Donald Trump to threaten an extra 100% tariff on goods from the Asian country, raising the possibility of an all-out trade war between the two economic giants.

The American finance chief described the Chinese move "economic coercion" and "a global supply chain control attempt."

Questioned on accepting the American proposal to participate in its dispute with the Asian nation, Reeves said she was "very concerned" by China's measures and urged the Beijing authorities "not to put up barriers and limit trade."

She said the move was "harmful for the global economy and generates additional headwinds."

"It is my opinion there are sectors where we should confront Chinese policies, but there are also important opportunities to sell into Chinese markets, including financial services and other sectors of the economic system. We've got to achieve that balance appropriate."

The Treasury chief also confirmed she was cooperating with G7 counterparts "on our own critical minerals strategy, so that we are less reliant."

NHS Medicine Costs and Funding

Reeves also acknowledged that the price the NHS spends on pharmaceuticals could increase as a result of ongoing discussions with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and funding.

A number of the biggest global drug companies have said in recent statements that they are either pausing or abandoning investments in the UK, with some blaming the insufficient payments they are getting.

Recently, the Science Minister said the price the NHS spends on medicines would have to rise to halt firms and pharmaceutical investment leaving the UK.

The Chancellor informed media: "It has been observed because of the cost structure, that drug testing, new drugs have not been offered in the United Kingdom in the extent that they are in other continental states."

"We want to guarantee that patients getting treatment from the NHS are can obtain the finest critical drugs in the world. And so we are looking at all of that, and... aiming to attract more investment into Britain."